THE ULTIMATE GUIDE TO PHARMACEUTICAL INGREDIENTS

“The present problem has uncovered some structural weaknesses during the EU’s medicines source chain and also a high dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides explained. She encouraged that supply chain issues be dealt with in an EU pharmaceutical strategy anticipated for being released by